Faron Pharmaceuticals Oy
LSE:FARN
Faron Pharmaceuticals Oy
Cash from Operating Activities
Faron Pharmaceuticals Oy
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Faron Pharmaceuticals Oy
LSE:FARN
|
Cash from Operating Activities
-€23.8m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
See Also
What is Faron Pharmaceuticals Oy's Cash from Operating Activities?
Cash from Operating Activities
-23.8m
EUR
Based on the financial report for Dec 31, 2023, Faron Pharmaceuticals Oy's Cash from Operating Activities amounts to -23.8m EUR.
What is Faron Pharmaceuticals Oy's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-3%
Over the last year, the Cash from Operating Activities growth was -4%. The average annual Cash from Operating Activities growth rates for Faron Pharmaceuticals Oy have been -11% over the past three years , -3% over the past five years .